Sildenafil Citrate Tablet, Film Coated
Product Images NDC 68788-8301

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 68788-8301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil Tablets 100mg (878b4c44 Cddc 42cb B9b5 911451ad1530 00)

Sildenafil Tablets 100mg (878b4c44 Cddc 42cb B9b5 911451ad1530 00)
Sildenafil Tablets 100 mg film-coated oral tablets label by Preferred Pharmaceuticals Inc., indicating it as a generic for Viagra. The label notes the product is manufactured by Ajanta Pharma USA Inc. It includes storage instructions and warnings, barcode, and directions for use in English and Spanish. The label has placeholders for lot, batch, and expiration information.*
FDA Label Image

Sildenafil_fig1.jpg (Sildenafil Fig1)

Sildenafil_fig1.jpg (Sildenafil Fig1)
A line graph depicting the mean change from baseline in sitting systolic blood pressure over time in healthy volunteers. The x-axis represents time post dose in hours (0 to 24), and the y-axis shows systolic blood pressure change in mmHg. Two lines compare Sildenafil 100 mg and placebo effects on blood pressure.*
FDA Label Image

Sildenafil_fig3 (Sildenafil Fig 3)

Sildenafil_fig3 (Sildenafil Fig 3)
A line graph showing the mean standing systolic blood pressure change from baseline over time (hours) following dose administration. It compares two treatment groups: Doxazosin plus placebo and Doxazosin plus Sildenafil 50 mg, with pressure change on the vertical axis and time postdose on the horizontal axis.*
FDA Label Image

Sildenafil_fig_4 (Sildenafil Fig 4)

Sildenafil_fig_4 (Sildenafil Fig 4)
Line graph depicting the mean standing systolic blood pressure change from baseline over 8 hours after dosing. The graph compares two treatment groups: Doxazosin combined with Sildenafil 100 mg and Doxazosin combined with placebo. The vertical axis shows blood pressure change in mmHg, and the horizontal axis shows time in hours after dosing.*
FDA Label Image

Sidenafil_fig_5 (Sildenafil Fig 5)

Sidenafil_fig_5 (Sildenafil Fig 5)
A line graph showing mean plasma concentrations of Sildenafil over time in healthy male volunteers. The x-axis represents time post dose in hours from 0 to 24, and the y-axis shows plasma concentrations in ng/mL up to 500. The curve peaks early then declines gradually. It is labeled as data for a Commercial Tablet treatment.*
FDA Label Image

Sildenafil-fig7 (Sildenafil Fig7)

Sildenafil-fig7 (Sildenafil Fig7)
Bar chart showing the percentage of patients reporting improvement across four treatments: placebo (24%), sildenafil tablets 25 mg (63%), sildenafil tablets 50 mg (74%), and sildenafil tablets 100 mg (82%). The x-axis lists treatment groups, and the y-axis represents the percentage of patients reporting improvement.*
FDA Label Image

Str (Sildenafil Structure)

Str (Sildenafil Structure)
Chemical structure of Sildenafil, the active ingredient in Sildenafil Citrate 100 mg tablets by Preferred Pharmaceuticals Inc. The image shows the molecular structure with distinct ring systems and functional groups typical of this compound.*
FDA Label Image

Figure2 (Sildenafil Fig2)

Figure2 (Sildenafil Fig2)
A line graph showing change in EBPM (mmHg) over time postdose (hours). It compares two groups: Doxazosin + Placebo and Doxazosin + Sildenafil 25 mg. The horizontal axis represents time from 0 to 8 hours, and the vertical axis shows EBPM change ranging from -40 to 20 mmHg.*
FDA Label Image

Sildenafil_fig6b (Sildenafil Fig6b)

Sildenafil_fig6b (Sildenafil Fig6b)
A bar chart illustrating the percentage of patients at endpoint by baseline score, with baseline scores on the x-axis (0 to 5) and percentage of patients on the y-axis (0 to 80). Multiple series are represented with different patterned bars, shown in a legend on the right side of the chart.*
FDA Label Image

Sildenafil_fig6a (Sildenafil Figure6a)

Sildenafil_fig6a (Sildenafil Figure6a)
A bar chart showing the percentage of patients at endpoint across different baseline scores ranging from 0 to 5. Different shaded bars correspond to score categories from 0 to 5 as indicated in the legend.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.